
AbstractThe role of apolipoproteins in cardiovascular disease has been well investigated, but their participation in cancer has only been explored in a few published studies which showed a close link with certain kinds of cancer. In this review, we focused on the function of different kinds of apolipoproteins in cancers, autophagy, oxidative stress, and drug resistance. The potential application of apolipoproteins as biomarkers for cancer diagnosis and prognosis was highlighted, together with an investigation of their potential as drug targets for cancer treatment. Many important roles of apolipoproteins and their mechanisms in cancers were reviewed in detail and future perspectives of apolipoprotein research were discussed.
autophagy, drug resistance, apolipoprotein, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Oxidative Stress, Apolipoproteins, Drug Resistance, Neoplasm, Neoplasms, Autophagy, cancer, oxidative stress, Animals, Humans, RC254-282, Cancer Biology
autophagy, drug resistance, apolipoprotein, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Oxidative Stress, Apolipoproteins, Drug Resistance, Neoplasm, Neoplasms, Autophagy, cancer, oxidative stress, Animals, Humans, RC254-282, Cancer Biology
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 121 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
